IBDEI1FF ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,248,0)
 ;;=SCI^14^27
 ;;^UTILITY(U,$J,358.4,249,0)
 ;;=SECONDARY V CODES AS APPROPRIATE^1^28
 ;;^UTILITY(U,$J,358.4,250,0)
 ;;=C&P EXAM^2^29
 ;;^UTILITY(U,$J,358.4,251,0)
 ;;=IDES C&P EXAM^3^29
 ;;^UTILITY(U,$J,358.4,252,0)
 ;;=ACE C&P EXAM^1^29
 ;;^UTILITY(U,$J,358.4,253,0)
 ;;=SEPARATION HEALTH ASSESSMENT (SHA)^4^29
 ;;^UTILITY(U,$J,358.4,254,0)
 ;;=LENGTHY/COMPLEX C-FILE REVIEW^2^30
 ;;^UTILITY(U,$J,358.4,255,0)
 ;;=EKG^1^30
 ;;^UTILITY(U,$J,358.4,256,0)
 ;;=RESPIRATORY/PFT^3^30
 ;;^UTILITY(U,$J,358.4,257,0)
 ;;=SHA/IDES EXAM^4^30
 ;;^UTILITY(U,$J,358.4,258,0)
 ;;=AUDIOLOGY^2^31
 ;;^UTILITY(U,$J,358.4,259,0)
 ;;=DENTAL^2^31
 ;;^UTILITY(U,$J,358.4,260,0)
 ;;=MEDICAL^3^31
 ;;^UTILITY(U,$J,358.4,261,0)
 ;;=MENTAL HEALTH^4^31
 ;;^UTILITY(U,$J,358.4,262,0)
 ;;=OPTOMETRY/oPHTHALMOLOGY^5^31
 ;;^UTILITY(U,$J,358.4,263,0)
 ;;=EXPOSURE TO HAZARDOUS SUB^1^31
 ;;^UTILITY(U,$J,358.4,264,0)
 ;;=INPATIENT ADMISSION VISIT^2^32
 ;;^UTILITY(U,$J,358.4,265,0)
 ;;=INPATIENT CONSULTS^1^32
 ;;^UTILITY(U,$J,358.4,266,0)
 ;;=INPATIENT SUBSEQUENT VISIT^3^32
 ;;^UTILITY(U,$J,358.4,267,0)
 ;;=DISCHARGE VISIT^4^32
 ;;^UTILITY(U,$J,358.4,268,0)
 ;;=OBSERVATION ADMISSION^5^32
 ;;^UTILITY(U,$J,358.4,269,0)
 ;;=OBSERVATION DISCHARGE^7^32
 ;;^UTILITY(U,$J,358.4,270,0)
 ;;=OBSERVATION SUBSEQUENT VISIT^6^32
 ;;^UTILITY(U,$J,358.4,271,0)
 ;;=CARDIAC^2^33
 ;;^UTILITY(U,$J,358.4,272,0)
 ;;=ENDOCRINE/METABOLIC^5^33
 ;;^UTILITY(U,$J,358.4,273,0)
 ;;=PULMONARY^20^33
 ;;^UTILITY(U,$J,358.4,274,0)
 ;;=EENT^4^33
 ;;^UTILITY(U,$J,358.4,275,0)
 ;;=MUSCULOSKELETAL^13^33
 ;;^UTILITY(U,$J,358.4,276,0)
 ;;=NEUROLOGIC^14^33
 ;;^UTILITY(U,$J,358.4,277,0)
 ;;=MENTAL HEALTH^12^33
 ;;^UTILITY(U,$J,358.4,278,0)
 ;;=GASTROENTEROLOGY^6^33
 ;;^UTILITY(U,$J,358.4,279,0)
 ;;=GU / RENAL^7^33
 ;;^UTILITY(U,$J,358.4,280,0)
 ;;=CANCER^3^33
 ;;^UTILITY(U,$J,358.4,281,0)
 ;;=HEMATOLOGIC & LYMPHATIC^8^33
 ;;^UTILITY(U,$J,358.4,282,0)
 ;;=INFECTIOUS DISEASE^10^33
 ;;^UTILITY(U,$J,358.4,283,0)
 ;;=SKIN^24^33
 ;;^UTILITY(U,$J,358.4,284,0)
 ;;=SIGNS, SYMPTOMS, CONDITIONS^22^33
 ;;^UTILITY(U,$J,358.4,285,0)
 ;;=INTERSTITIAL LUNG DISEASE^11^33
 ;;^UTILITY(U,$J,358.4,286,0)
 ;;=PAIN^18^33
 ;;^UTILITY(U,$J,358.4,287,0)
 ;;=OTHER^17^33
 ;;^UTILITY(U,$J,358.4,288,0)
 ;;=COMMON PULMONARY DIAGNOSES^1^33
 ;;^UTILITY(U,$J,358.4,289,0)
 ;;=NEUROMUSCULAR/SKELETAL^15^33
 ;;^UTILITY(U,$J,358.4,290,0)
 ;;=OCCUPATIONAL^16^33
 ;;^UTILITY(U,$J,358.4,291,0)
 ;;=PLEURAL DISEASE^19^33
 ;;^UTILITY(U,$J,358.4,292,0)
 ;;=RADIATION^21^33
 ;;^UTILITY(U,$J,358.4,293,0)
 ;;=SKELETAL^23^33
 ;;^UTILITY(U,$J,358.4,294,0)
 ;;=HEPATIC & BILIARY^9^33
 ;;^UTILITY(U,$J,358.4,295,0)
 ;;=SUTURES/DRESSINGS^25^33
 ;;^UTILITY(U,$J,358.4,296,0)
 ;;=VASCULAR^26^33
 ;;^UTILITY(U,$J,358.4,297,0)
 ;;=BEDSIDE PROCEDURES^1^34
 ;;^UTILITY(U,$J,358.4,298,0)
 ;;=BLOODS,ARTERIAL & VENOUS^2^34
 ;;^UTILITY(U,$J,358.4,299,0)
 ;;=BRONCHOSCOPY^3^34
 ;;^UTILITY(U,$J,358.4,300,0)
 ;;=EXERCISE TESTING^4^34
 ;;^UTILITY(U,$J,358.4,301,0)
 ;;=OXIMETRY^6^34
 ;;^UTILITY(U,$J,358.4,302,0)
 ;;=PULMONARY FUCTION TESTING^7^34
 ;;^UTILITY(U,$J,358.4,303,0)
 ;;=RESPIRATORY THERAPY^8^34
 ;;^UTILITY(U,$J,358.4,304,0)
 ;;=THORACENTESIS^9^34
 ;;^UTILITY(U,$J,358.4,305,0)
 ;;=INTENSIVE CARE^5^34
 ;;^UTILITY(U,$J,358.4,306,0)
 ;;=NEW PATIENT^2^35
 ;;^UTILITY(U,$J,358.4,307,0)
 ;;=ESTABLISHED PATIENT^1^35
 ;;^UTILITY(U,$J,358.4,308,0)
 ;;=CONSULTATIONS^3^35
 ;;^UTILITY(U,$J,358.4,309,0)
 ;;=BIOPSY/DEBRIDEMENT^1^36
 ;;^UTILITY(U,$J,358.4,310,0)
 ;;=I&D/ASPIRATION^10^36
 ;;^UTILITY(U,$J,358.4,311,0)
 ;;=DESTRUCT-BENIGN/PREMALIG LESIONS^3^36
